Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105Laurence M. Wood, Yvonne Paterson, Zhen-Kun Pan et al.|Cancer Immunology Immunotherapy|2011Cited by 69
The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapyLaurence M. Wood, Yvonne Paterson, Zhen-Kun Pan et al.|Cancer Immunology Immunotherapy|2011Cited by 54
Listeria monocytogenes-Derived Listeriolysin O Has Pathogen-Associated Molecular Pattern-Like Properties Independent of Its Hemolytic AbilityAnu Wallecha, Yvonne Paterson, Laurence M. Wood et al.|Clinical and Vaccine Immunology|2012Cited by 44
Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapyLaurence M. Wood, Yvonne Paterson, Zhen-Kun Pan et al.|Cancer Immunology Immunotherapy|2010Cited by 26
ISG15 as a Novel Target for Tumor Immunotherapy (95.13)Laurence M. Wood, Yvonne Paterson, Matthew M. Seavey et al.|The Journal of Immunology|2010Cited by 1